Development of a Pharmacogenetic Lab-on-Chip Assay Based on the In-Check Technology to Screen for Genetic Variations Associated to Adverse Drug Reactions to Common Chemotherapeutic Agents

Background: Antineoplastic agents represent the most common class of drugs causing Adverse Drug Reactions (ADRs). Mutant alleles of genes coding for drug-metabolizing enzymes are the best studied individual risk factors for these ADRs. Although the correlation between genetic polymorphisms and ADRs...

Descripción completa

Detalles Bibliográficos
Autores principales: Iemmolo, Rosario, La Cognata, Valentina, Morello, Giovanna, Guarnaccia, Maria, Arbitrio, Mariamena, Alessi, Enrico, Cavallaro, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764726/
https://www.ncbi.nlm.nih.gov/pubmed/33317085
http://dx.doi.org/10.3390/bios10120202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764726/
https://www.ncbi.nlm.nih.gov/pubmed/33317085
http://dx.doi.org/10.3390/bios10120202

Ejemplares similares